For the TC regimen, the most pronounced intergroup differences occurred at cycle 4, with the HBV-infected group exhibiting the highest median ALT (56 U/L) and AST (39 U/L) among all regimens (p < 0.05 vs. baseline and past-infection group). The gene discussed is GPT; the disease is infection.